Latest News On Cancer

Latest California Healthline Stories

Oncology Doctors Say the Build Back Better Act Will Slash Cancer Care Funding — A Skewed Argument

The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.

Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment

Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.

‘Luckiest Man Alive’: Why 9/11 First Responders’ Outlooks May Improve Even as Physical Health Fails

The New York City Fire Department’s 20-year report on the health consequences of the 9/11 terrorist attacks finds that first responders consistently report mental health quality-of-life indicators that are better than those of average Americans, even as their physical health declines.

‘Kicking You When You’re Down’: Many Cancer Patients Pay Dearly for Parking

Patients often fork over payments comparable to valet rates to park while receiving care. A recent study found that some of the country’s most prestigious cancer centers charge nearly $1,700 over the course of treatment for some types of the disease.

Getting a Prescription to Die Remains Tricky Even as Aid-in-Dying Bills Gain Momentum

Access to physician-assisted death is expanding across the U.S., but the procedure remains in Montana’s legal gray zone more than a decade after the state Supreme Court ruled physicians could use a dying patient’s consent as a defense.

Gene Screenings Hold Disease Clues, but Unexplained Anomalies Often Raise Fears

Multiple-gene panel tests are frequently offered to patients at risk for diseases such as cancer that can assess more than 80 genes. But in screening a wide variety of genes, doctors might see a variant that hasn’t yet been deciphered and be unable to explain its significance, leaving patients with concerns and no answers.